Cargando…

Vardenafil Activity in Lung Fibrosis and In Vitro Synergy with Nintedanib

Idiopathic pulmonary fibrosis (IPF) remains an intractably fatal disorder, despite the recent advent of anti-fibrotic medication. Successful treatment of IPF, like many chronic diseases, may benefit from the concurrent use of multiple agents that exhibit synergistic benefit. In this light, phosphodi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bourne, Michael H., Kottom, Theodore J., Hebrink, Deanne M., Choudhury, Malay, Leof, Edward B., Limper, Andrew H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699915/ https://www.ncbi.nlm.nih.gov/pubmed/34944010 http://dx.doi.org/10.3390/cells10123502

Ejemplares similares

Dysbiosis of the intestinal fungal microbiota increases lung resident group 2 innate lymphoid cells and is associated with enhanced asthma severity in mice and humans
por: Kanj, Amjad N., et al.
Publicado: (2023)

Lung Epithelial Cell Line Immune Responses to Pneumocystis
por: Kottom, Theodore J., et al.
Publicado: (2023)

Survey of the Transcription Factor Responses of Mouse Lung Alveolar Macrophages to Pneumocystis murina
por: Kottom, Theodore J., et al.
Publicado: (2021)

Current State of Carbohydrate Recognition and C-Type Lectin Receptors in Pneumocystis Innate Immunity
por: Kottom, Theodore J., et al.
Publicado: (2021)

Effects of Nintedanib on Quantitative Lung Fibrosis Score in Idiopathic Pulmonary Fibrosis
por: Lancaster, Lisa, et al.
Publicado: (2020)

Cigarette smoke promotes dendritic cell accumulation in COPD; a Lung Tissue Research Consortium study
por: Vassallo, Robert, et al.
Publicado: (2010)

Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume
por: Kolb, Martin, et al.
Publicado: (2017)

Additional C-type lectin receptors mediate interactions with Pneumocystis organisms and major surface glycoprotein
por: Kottom, Theodore J., et al.
Publicado: (2021)

Nintedanib prevented fibrosis progression and lung cancer growth in idiopathic pulmonary fibrosis
por: Fukunaga, Kentaro, et al.
Publicado: (2018)

Isolation and identification of a novel vardenafil analogue, propoxy-vardenafil, found as an adulterant in a health supplement
por: Sun, Jian, et al.
Publicado: (2023)

The Effect of Nintedanib in Post-COVID-19 Lung Fibrosis: An Observational Study
por: Saiphoklang, Narongkorn, et al.
Publicado: (2022)

Preclinical and Toxicology Studies of BRD5529, a Selective Inhibitor of CARD9
por: Kottom, Theodore J., et al.
Publicado: (2022)

Effects of Nintedanib in an Animal Model of Liver Fibrosis
por: Wollin, Lutz, et al.
Publicado: (2020)

Reducing lung function decline in patients with idiopathic pulmonary fibrosis: potential of nintedanib
por: Woodcock, Hannah V, et al.
Publicado: (2013)

Correction of Chloride Transport and Mislocalization of CFTR Protein by Vardenafil in the Gastrointestinal Tract of Cystic Fibrosis Mice
por: Dhooghe, Barbara, et al.
Publicado: (2013)

Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis
por: Wollin, Lutz, et al.
Publicado: (2015)

Treatment with nintedanib for acute exacerbation of idiopathic pulmonary fibrosis
por: Tomioka, Hiromi, et al.
Publicado: (2017)

Efficacy and safety of nintedanib in advanced idiopathic pulmonary fibrosis
por: Yoon, Hee-Young, et al.
Publicado: (2018)

Clinical use of nintedanib in patients with idiopathic pulmonary fibrosis
por: Hajari Case, Amy, et al.
Publicado: (2017)

Protective Effects of Nintedanib against Polyhexamethylene Guanidine Phosphate-Induced Lung Fibrosis in Mice
por: Kim, Hyeon-Young, et al.
Publicado: (2018)

Vardenafil for the treatment of erectile dysfunction: an overview of the clinical evidence
por: Morales, Antonio Martín, et al.
Publicado: (2009)

Use of nintedanib in patients with idiopathic pulmonary fibrosis: Initial Indian experience
por: Mullerpattan, Jai B, et al.
Publicado: (2019)

Nintedanib: evidence for its therapeutic potential in idiopathic pulmonary fibrosis
por: Inomata, Minoru, et al.
Publicado: (2015)

Safety, tolerability and appropriate use of nintedanib in idiopathic pulmonary fibrosis
por: Corte, Tamera, et al.
Publicado: (2015)

Efficacy and Safety of Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis: An Update
por: Rodríguez-Portal, José Antonio
Publicado: (2017)

Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis
por: Flaherty, Kevin R., et al.
Publicado: (2018)

Effects of nintedanib in patients with idiopathic pulmonary fibrosis by GAP stage
por: Ryerson, Christopher J., et al.
Publicado: (2019)

Colitis Associated with Nintedanib Therapy for Idiopathic Pulmonary Fibrosis (IPF)
por: Oda, Keishi, et al.
Publicado: (2017)

Pulmonary Hypertension Exacerbated by Nintedanib Administration for Idiopathic Pulmonary Fibrosis
por: Shimomura, Iwao, et al.
Publicado: (2018)

Left ventricular dysfunction in an idiopathic pulmonary fibrosis patient on nintedanib
por: Imai, Ryosuke, et al.
Publicado: (2020)

Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis
por: Richeldi, Luca, et al.
Publicado: (2020)

Nintedanib treatment for pulmonary fibrosis after coronavirus disease 2019
por: Ogata, Hiroaki, et al.
Publicado: (2021)

Leveraging ageing models of pulmonary fibrosis: the efficacy of nintedanib in ageing
por: Kato, Kosuke, et al.
Publicado: (2021)

Safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis in Brazil
por: Pereira, Carlos Alberto de Castro, et al.
Publicado: (2019)

Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
por: Hostettler, Katrin E, et al.
Publicado: (2014)

Vardenafil como tratamiento en la disfunción eréctil : revisión bibliográfica
por: Rasgado Díaz, Fernando
Publicado: (2006)

Acute Effects of Vardenafil on Pulmonary Artery Responsiveness in Pulmonary Hypertension
por: Karasu-Minareci, Edibe, et al.
Publicado: (2012)

The effects of vardenafil and pentoxifylline administration in an animal model of ischemic colitis
por: Aziret, Mehmet, et al.
Publicado: (2014)

Anti-fibrotic efficacy of nintedanib in pulmonary fibrosis via the inhibition of fibrocyte activity
por: Sato, Seidai, et al.
Publicado: (2017)

Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases
por: Wollin, Lutz, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0dihbq4l66vbci7bt3rkjcr0j0